French Biotech gets an EU CRISPR Patent for CAR-T Research – Labiotech.eu (blog)
|
French Biotech gets an EU CRISPR Patent for CAR-T Research
Labiotech.eu (blog) The new European patent granted to Cellectis covers the use of RNA-guided endonucleases in primary T cells, which includes both the Cas9 and Cpf1 versions of CRISPR. The patent will protect the application of CRISPR gene editing to T cell research … |
